Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
Despite the widespread awareness that hypertension and dyslipidemia are risk factors of prime importance for cardiovascular disease, the prevalence of these risk factors is still high, and the success of their control can hardly be considered satisfactory. The latest European guidelines for the mana...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2020-11-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2315 |